Speakers
Brian Booth
Principal Scientist
Shape Therapeutics
Day One
Tuesday April 5, 2022
11:45 am | Enhanced gRNA Expression & Recruitment of Endogenous ADAR to Drive Robust RNA Editing in vivo
Daniel Rosan
Chief Business & Financial Officer
Ascidian Therapeutics
Day Two
Wednesday April 6, 2022
3:15 pm | Re-Engineering the Transcriptome via RNA Exon Editing: A Novel Therapeutic Approach
Dave Mauger
Director of Data Science
Arrakis Therapeutics
Day Two
Wednesday April 6, 2022
12:15 pm | Discovering Targetable mRNA Structures in the Transcriptome
David Guay
Vice President of Innovation
Feldan Therapeutics
Day Two
Wednesday April 6, 2022
2:15 pm | Shuttle Peptides Enable Delivery of Splice Switching ASOs to Airway Epithelial Cells
Pre-Conference Day
Sunday 11th June 2023
12:00 pm | Assessing Novel Delivery Technologies to Achieve Specific Targeting
Feng Damon Wang
Post Doc Associate, Jon Watts Lab (RNA Therapeutics Institute
UMass Chan Medical School
Day Two
Wednesday April 6, 2022
3:45 pm | G-Rich Motifs within Phosphorothioate-Based ASOs Drive Activation of FXN Expression through Indirect Effects
Gerard Platenburg
Chief Scientific Officer & Co-Founder
ProQR
Day One
Tuesday April 5, 2022
4:00 pm | Harnessing RNA Chemical Modifications to Improve the Potency & Yield of ADAR
Gurumurthy Channabasavaiah
Professor
Nebraska Medical Center
Pre-Conference Day
Sunday 11th June 2023
12:00 pm | Assessing Novel Delivery Technologies to Achieve Specific Targeting
Hagen Cramer
Chief Production Officer
QurAlis
Pre-Conference Day
Sunday 11th June 2023
3:00 pm | Unlocking Efficient Oligonucleotide Manufacturing in Line with Regulatory Expectations
Ian Harding
Scientist II
Wave Life Sciences
Day One
Tuesday April 5, 2022
3:30 pm | Pioneering New Applications of RNA Editing & Reaching Larger Patient Populations
Jonathan Gootenberg
McGovern Fellow
MIT
Day One
Tuesday April 5, 2022
10:15 am | New Molecular Technologies for RNA Editing & Control
Kunwoo Lee
Chief Executive Officer & Co-founder
GenEdit
Day One
Tuesday April 5, 2022
2:30 pm | Non-Lipid Delivery of Genome Editing with Hydrophilic Nanoparticles
Mateusz Maciejewski
Vice President, Head of Data Science
Korro Bio
Day Two
Wednesday April 6, 2022
11:15 am | Applying Data Science & Machine Learning Approaches to Improve Efficacy of ADAR
Miriam Bujny
Chief Development Officer
Sapreme Technologies
Day One
Tuesday April 5, 2022
2:00 pm | Efficient On-Target Delivery of Oligonucleotides (& Beyond): in vitro & in vivo Performance of Sapreme’s Endosomal Escape Enhancers for Various Tissues & Targets
Mohamed ElSayed
Executive Vice President & Chief Technology Officer
RVAC Medicines
Day One
Tuesday April 5, 2022
9:30 am | Panel Discussion: Conceptualizing the Evolution of RNA Therapeutics
Nagy Habib
Head of Research
MiNA Therapeutics
Day One
Tuesday April 5, 2022
9:30 am | Panel Discussion: Conceptualizing the Evolution of RNA Therapeutics
Pre-Conference Day
Sunday 11th June 2023
9:00 am | Leveraging ADAR & APOBEC to Reactivate Downregulated Genes in Rare Disease
Naveen Krishnan
Senior Director of Venture Investment
Bayer
Day Two
Wednesday April 6, 2022
9:30 am | Panel Discussion: Exploring Unique Challenges for the Development of RNA Editing Therapies
Omar Abudayyeh
McGovern Fellow
MIT
Day One
Tuesday April 5, 2022
10:15 am | New Molecular Technologies for RNA Editing & Control
Paul Bolno
President & Chief Executive Officer
Wave Life Sciences
Day One
Tuesday April 5, 2022
9:30 am | Panel Discussion: Conceptualizing the Evolution of RNA Therapeutics
Day Two
Wednesday April 6, 2022
9:30 am | Panel Discussion: Exploring Unique Challenges for the Development of RNA Editing Therapies
Prashant Monian
Senior Scientist
Wave Life Sciences
Day One
Tuesday April 5, 2022
9:00 am | The First Clinical Candidate for RNA Editing
Raj Pandey
Vice President of Chemistry
Cargene
Pre-Conference Day
Sunday 11th June 2023
3:00 pm | Unlocking Efficient Oligonucleotide Manufacturing in Line with Regulatory Expectations
Ron Hause
Vice President & Head of Analytics & Informatics
Shape Therapeutics
Day Two
Wednesday April 6, 2022
11:45 am | Generative Machine Learning Enables DGuide RNA Design for Precise RNA Editing
Ron Weiss
Professor
MIT
Day One
Tuesday April 5, 2022
4:30 pm | Developing a New Control System for Synthetic Genes to Control the Payload in Efforts to Improve Potency & Durability
Sandy Hinckley
Senior Director, Head of Discovery Biology
QurAlis
Day Two
Wednesday April 6, 2022
1:45 pm | Case Study: Recent Advances in Splice Switching ASOs for CNS Diseases
Steven Seedhouse
Managing Director, Biotechnology Equity Research
Raymond James
Day Two
Wednesday April 6, 2022
9:30 am | Panel Discussion: Exploring Unique Challenges for the Development of RNA Editing Therapies
Thomas de Vlaam
Principal
VC Pillar
Day Two
Wednesday April 6, 2022
9:00 am | Mapping the RNA Editing R&D Landscape: A 2023 Forecast
Venkata Krishnamurthy
Senior Vice President, Head of Platform
Korro Bio
Day One
Tuesday April 5, 2022